BAŞCI, S. Et Al. 2020. Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents. Medical Laboratory Technology Journal , vol.6, no.2 , 92-99.

BAŞCI, S., YİĞENOĞLU, T. N., UNCU ULU, B., BAKIRTAŞ, M., ŞAHİN, D., DARÇIN, T., ... YILDIZ, J.(2020). Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents. Medical Laboratory Technology Journal , vol.6, no.2, 92-99.

BAŞCI, SEMİH Et Al. "Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents," Medical Laboratory Technology Journal , vol.6, no.2, 92-99, 2020

BAŞCI, SEMİH Et Al. "Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents." Medical Laboratory Technology Journal , vol.6, no.2, pp.92-99, 2020

BAŞCI, S. Et Al. (2020) . "Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents." Medical Laboratory Technology Journal , vol.6, no.2, pp.92-99.

@article{article, author={SEMİH BAŞCI Et Al. }, title={Early Relapse After Autologous Stem Cell Transplantation in Multiple Myeloma is Still Prognostic in The Era of Novel Agents}, journal={Medical Laboratory Technology Journal}, year=2020, pages={92-99} }